Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteopgen.com
Twitter@OpGen
CategoryBioTech
Phone301.869.9683
Employees
Founded2002
DescriptionOptical Mapping

Offices

Gaithersburg, USA
708 Quince Orchard Road
Gaithersburg, MD, 20878
USA

People

CEO
Chairman of the Board
CFO
CIO
Sr. VP, Commercial Operations
Board of Directors
Board Member
Director
Show All People

Investments

BioRelix 3/2012

Funding

Tags

OpGen

OpGen, Inc is a privately-held company, based in Gaithersburg, MD, and focused on commercializing rapid, high precision solutions for DNA analysis and genomics with the Argus® Whole Genome Mapping System and MapIt® Services. Using the proprietary technologies provided by OpGen, customers in academic, government, biodefense and research labs as well as premier genome centers around the world can view ordered whole genome maps for a wide range of applications including strain typing for early outbreak response, improved sequence assembly of microbial and now large genomes up to 3 Gb and comparative genomics applications.

OpGen Community (Linkedin Group) provides an accessible environment to share information, exchange questions and best practices using OpGen’s technologies in a variety of applications.

Recent Milestones

  • Dollar
    OpGen received $4M in Debt funding. (4/7/14)
    Posted 1/6/14 at 2:52am via sec.gov
  • Check
    OpGen — OpGen Announces Partnership with University of California, Davis, to Develop High Resolution Microbial Genetic Maps in Support of The 100K Genome Project (12/19/12)
    Posted 2/20/13 at 3:59am via opgen.com
  • Dollar
    OpGen invested in BioRelix. (3/22/12)
    Posted 3/22/12 at 6:19pm via masshightech.com
  • Dollar
    OpGen received $17M in Series C funding. (3/7/12)
    Posted 3/12/12 at 6:15pm via bizjournals.com
  • Dollar
    OpGen received $3.53M in Debt funding. (2/16/12)
    Posted 9/2/13 at 8:33pm via sec.gov
  • Check
    OpGen — OpGen Topping Off Series B Round For DNA-Analysis Instrument Sales (2/9/11)
    Posted 2/8/11 at 7:57pm via dowjones.com
  • Dollar
    OpGen received $17M in Series B funding. (9/28/10)
    Posted 9/27/10 at 9:41pm via opgen.com
  • Dollar
    OpGen received $4.02M in Debt funding. (5/10/10)
    Posted 12/9/13 at 11:28pm via sec.gov
  • Dollar
    OpGen received $4.05M in Debt funding. (1/15/10)
    Posted 12/2/13 at 10:19pm via sec.gov
  • Check
    OpGen added Evan Jones as Interim CEO. (12/1/09)
    Posted 12/11/09 at 5:30pm
  • Dollar
    OpGen received $23.6M in Series A funding. (9/12/07)
    Posted 3/12/10 at 3:50am via opgen.com
  • Check
    OpGen added Douglas White as CEO.
    Posted 2/20/13 at 3:52am
  • Check
    OpGen added Trevor D'Souza as Observer.
    Posted 12/11/09 at 5:30pm
  • Check
    OpGen added Eric Winzer as CFO.
    Posted 2/20/13 at 3:52am
  • Check
    OpGen added Noel Doheny as CEO.
    Posted 2/19/14 at 11:57pm

Videos

Screenshots

OpGen screenshot
Above: OpGen
Uploaded: 3/12/10

Sources

  1. Connecticut biotech raises $2.56M round (masshightech.com) [edit]
  2. OpGen Announces $23.6 Million Series A Financing (opgen.com) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
  5. OpGen Completes $17 Million Series B Financing (opgen.com) [edit]
  6. SEC (sec.gov) [edit]
  7. OpGen raises another $17 million in VC (bizjournals.com) [edit]
  8. SEC (sec.gov) [edit]
  9. OpGen Topping Off Series B Round For DNA-Analysis Instrument Sales (fis.dowjones.com) [edit]
    OpGen Announces Partnership with University of California, Davis, to Develop High Resolution Microbial Genetic Maps in Support of The 100K Genome Project (opgen.com) [edit]
Edit This Page
Last Edited 4/7/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy